Cathleen Mccabe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ESCRS presentations will feature clinical data on APX3330 in diabetic retinopathy; Nyxol® data in presbyopia, dim light vision disturbance and reversal of pharmacologically induced mydriasisFARMINGTON HILLS, Mich., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that it will pre

Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate... | May 1, 2023

Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate

Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1New data demonstrates comparable range of vision and intermediate visual acuity between Clareon monofocal IOL and TECNIS Eyhance* monofocal IOL2Alcon advances next-generation workflow conn...

Press release content from Business Wire. The AP news staff was not involved in its creation.